Clinical Trials for Recurrent Laryngeal Squamous Cell Carcinoma

Find clinical trials for recurrent laryngeal squamous cell carcinoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT ID: NCT06589804

This clinical trial is studying whether adding a medication called cetuximab to the standard treatment pembrolizumab can better help patients with certain types of head and neck cancers that have r...

Recruiting

Phase: PHASE3 Type: interventional Locations: Saint Louis, Missouri, United States, Flint, Michigan, United States +95 more

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

NCT ID: NCT04671667

This clinical trial is exploring whether a drug called pembrolizumab, which helps the immune system fight cancer, is more effective on its own compared to the standard treatment of chemotherapy and...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +169 more

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT ID: NCT06980038

This clinical trial is exploring whether a combination of two treatments, cemiplimab (REGN2810) and CDX-1140, is more effective than using cemiplimab alone for patients with advanced head and neck ...

Not yet recruiting

Phase: PHASE2 Type: interventional

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

NCT ID: NCT06868433

This clinical trial is testing a new treatment approach for patients with certain types of head and neck cancer that has either returned after treatment or spread to other parts of the body. The st...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT ID: NCT06662058

This clinical trial is looking at how offering hearing tests close to home or through remote options can help monitor hearing loss in patients with certain types of head and neck cancers who are re...

Recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

NCT ID: NCT04754321

This clinical trial is investigating a new treatment approach for patients with persistent or recurrent head and neck cancer, specifically looking at how well the combination of a medication called...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Lovastatin and Pembrolizumab for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

NCT ID: NCT06636734

The LAPP Trial is a research study looking at how well two medications, lovastatin and pembrolizumab, work together to treat patients with certain types of head and neck cancer that have either ret...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions